We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

000728:SZSEGuoyuan Securities Company Limited Analysis

Data as of 2026-07-17 - not real-time

CN¥7.28

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Guoyuan Securities is trading at ¥7.28, below its 20‑day SMA of ¥7.46 and well under the 200‑day SMA of ¥8.05, indicating a down‑trend bias. The RSI sits at 47.5, suggesting neutral momentum, while the MACD histogram is negative and the signal line is bearish, reinforcing short‑term downside pressure. Volume has been decreasing, and the 30‑day volatility is high at 33%, pointing to a choppy trading environment. Nonetheless, the stock’s PE of 13.7 is materially lower than the industry average of 18, and the price‑to‑book of 0.82 is below parity, flagging a value tilt. The dividend yield of 3.8% with a payout ratio of 34% appears comfortable given the positive operating cash flow. However, the balance sheet is strained, with a debt‑to‑equity ratio of 267% and net debt exceeding cash.
A discounted cash‑flow model assigns a fair value of ¥28.4, implying roughly 36% upside and supporting an undervalued classification. The beta of 0.37 signals low market sensitivity, which, combined with the strong dividend yield, makes the stock attractive for defensive investors. The fear‑greed index at “Extreme Greed” suggests market optimism that could lift the price toward analyst median targets near ¥10.5. Yet, high leverage and a recent 30% drawdown temper expectations, especially in a regulated Chinese capital‑markets environment. Overall, the stock offers a compelling value proposition but carries notable financial and regulatory risks.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD and decreasing volume suggest limited upside in the near term
  • Price is near the technical support level of ¥7.01
  • High short‑term volatility may cause price swings

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF fair value indicates ~36% upside
  • Attractive dividend yield of 3.8% with a low payout ratio
  • Low beta provides defensive characteristics

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant valuation gap between market price and intrinsic value
  • Strong cash position relative to operating cash flow despite high leverage
  • Potential earnings recovery and continued dividend sustainability

Key Metrics & Analysis

Financial Health

Revenue Growth-12.80%
Profit Margin38.59%
P/E Ratio13.7
ROE6.12%
ROA1.23%
Debt/Equity267.33
P/B Ratio0.8
Op. Cash FlowCN¥15.2B
Industry P/E18.0

Technical Analysis

TrendNeutral
RSI47.5
SupportCN¥7.01
ResistanceCN¥8.02
MA 20CN¥7.46
MA 50CN¥7.25
MA 200CN¥8.05
MACDBearish
VolumeDecreasing
Fear & Greed Index88.66

Valuation

Fair ValueCN¥28.43
Target PriceCN¥9.90
Upside/Downside35.99%
GradeUndervalued
TypeValue
Dividend Yield3.80%

Risk Assessment

Beta0.37
Volatility33.29%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.